Results 151 to 160 of about 35,390 (262)

Electrophysiological Characteristics of Atrial Fibrillation Trigger Sites During Ongoing Atrial Fibrillation Using Ultra‐High‐Resolution Mapping

open access: yesJournal of Arrhythmia, Volume 42, Issue 3, June 2026.
AF trigger sites exhibited a markedly shorter minimum local cycle length during ongoing AF, suggesting transient rapid activity. Ultra‐high‐resolution mapping during ongoing AF may provide complementary mechanistic information when conventional trigger mapping is inconclusive.
Kohki Nakamura   +10 more
wiley   +1 more source

Efficacy of a Novel Ablation Index Algorithm for Cavotricuspid Isthmus Ablation Using a Flexible‐Tip Ablation Catheter

open access: yesJournal of Arrhythmia, Volume 42, Issue 3, June 2026.
AutoMark Index (AI) is a novel ablation algorithm that combines contact force, radiofrequency current, and application to provide real‐time lesion formation. AI‐guided CTI ablation protocol is efficient in shortening RF duration for acute bidirectional CTI block and CTI procedure time compared to the conventional 40 W ablation protocol.
Koji Sudo   +11 more
wiley   +1 more source

Dexmedetomidine–saves the day

open access: yesIndian Journal of Anaesthesia, 2013
Tasneem S Dhansura   +2 more
openaire   +3 more sources

Entrance‐Site Ablation in Atrial Tachycardia Involving Epicardial Conduction: A Case Series

open access: yesJournal of Arrhythmia, Volume 42, Issue 3, June 2026.
In patients with AT involving epicardial conduction, a systematic entrainment‐guided approach to identify and ablate the entrance site proved effective when conventional exit‐site ablation was insufficient. ABSTRACT Background Treatment of atrial tachycardia (AT) involving epicardial conduction remains challenging.
Yuichiro Sakamoto   +5 more
wiley   +1 more source

Host–Pathogen Dual Targeting With Repurposed Drugs Identifies a Synergistic Therapy for Intracellular Staphylococcus aureus

open access: yesMicrobiologyOpen, Volume 15, Issue 3, June 2026.
A large intracellular drug‐repurposing screen identifies a potent synergy between 5‐fluoro‐2′‐deoxycytidine and rifapentine, acting through dual host–pathogen targeting to reduce Staphylococcus aureus burdens across strains, cell types, and infection models (created with BioRender).
Blanca Lorente‐Torres   +13 more
wiley   +1 more source

Encephalopathy: Cause, Pathogenesis, and Treatment

open access: yesMedComm, Volume 7, Issue 6, June 2026.
Various encephalopathies (sepsis‐associated, hepatic, hypoxic–ischemic, diabetic, uremic, toxic) have incompletely elucidated pathogenesis, which severely restricts targeted therapy development. Small molecule drugs show unique multitarget potential but face toxicity, poor blood–brain barrier penetration and unclear specificity.
Shimeng Lv   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy